Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DermaKB Shampoo is a **topical scalp-care therapeutic product** developed by **Kane Biotech** for dandruff, seborrheic dermatitis, and related scalp conditions characterized by irritation, itchiness, and flaking. Its core active technology is **coactiv+**, a chelating-based anti-biofilm system composed of ingredients including **trisodium citrate, citric acid, and disodium EDTA**, designed to disrupt **bacterial and fungal biofilms** on the scalp rather than acting through a classic single-receptor pharmacology model. The formulation also includes supportive topical ingredients such as **colloidal oatmeal, burdock root extract, D-panthenol, and allantoin**. It is marketed under the DermaKB brand in liquid shampoo and shampoo bar formats and has been described as using ingredients designated GRAS and as being approved by the Canadian Dermatology Association.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DermaKB Shampoo.